SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001829126-23-004381
Filing Date
2023-06-23
Accepted
2023-06-23 16:05:16
Documents
2
Group Members
DAVID E. LAZAR

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 5 TO THE SCHEDULE 13D titanpharma_sc13da5.htm SC 13D/A 48826
2 SHARE TRANSFER AGREEMENT, DATED JUNE 21, 2023 titanpharma_ex99-3.htm EX-99.3 168232
  Complete submission text file 0001829126-23-004381.txt   218634
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Subject) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-46083 | Film No.: 231037666
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR. NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR. NEW YORK NY 10036 646 768 8417
Activist Investing LLC (Filed by) CIK: 0001817604 (see all company filings)

IRS No.: 833953038 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D/A